Literature DB >> 31575425

Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.

Adrián I Löffler1, Jonathan A Pan1, Pelbreton C Balfour1, Peter W Shaw1, Yang Yang2, Moiz Nasir1, Daniel A Auger3, Frederick H Epstein3, Christopher M Kramer4, Li-Ming Gan5, Michael Salerno6.   

Abstract

Heart failure with preserved ejection fraction (HFpEF) is frequently accompanied by co-morbidities and a systemic proinflammatory state, resulting in coronary microvascular dysfunction (CMD), as well as myocardial fibrosis. The purpose of this study is to examine the relation between myocardial perfusion reserve (MPR) and diffuse myocardial fibrosis in patients with HFpEF using cardiovascular magnetic resonance. A single center study was performed in 19 patients with clinical HFpEF and 15 healthy control subjects who underwent quantitative first-pass perfusion imaging to calculate global MPR. T1 mapping was used to assess fibrosis and to calculate extracellular volume. Spiral cine displacement encoded stimulated echo was used to calculate myocardial strain. Comprehensive 2D echocardiograms with speckle tracking, cardiopulmonary exercise testing, and brain natriuretic peptide levels were also obtained. In patients with HFpEF, mean left ventricular EF was 61% ± 9% and left ventricular mass index 45 ± 12 g/m2. Compared with controls, HFpEF patients had reduced global MPR (2.29 ± 0.64 vs 3.38 ± 0.76, p = 0.002) and VO2 max (16.5 ± 6.8 vs 30.9 ± 7.7 ml/kg min, p <0.001) whereas extracellular volume (0.29 ± 0.04 vs 0.25 ± 0.04, p = 0.02), pulmonary artery systolic pressure (35.4 ± 13.7 vs 22.3 ± 5.4 mm Hg, p = 0.004), and average E/e' (15.0 ± 7.6 vs 8.6 ± 2.0, p = 0.005) were increased. Displacement encoded stimulated echo peak systolic circumferential strain (p = 0.60) as well as echocardiographic derived global longitudinal strain (p = 0.07) were similar between both groups. The prevalence of CMD, defined as global MPR <2.5, in the HFpEF group was 69%. In conclusion, HFpEF patients have a high prevalence of CMD and diffuse fibrosis. These parameters may be useful clinical end points for future therapeutic trials.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31575425      PMCID: PMC6894613          DOI: 10.1016/j.amjcard.2019.08.011

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  35 in total

Review 1.  New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function.

Authors:  Michael R Zile; Dirk L Brutsaert
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

2.  Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction.

Authors:  Kajenny Srivaratharajah; Thais Coutinho; Robert deKemp; Peter Liu; Haissam Haddad; Ellamae Stadnick; Ross A Davies; Sharon Chih; Girish Dwivedi; Ann Guo; George A Wells; Jordan Bernick; Robert Beanlands; Lisa M Mielniczuk
Journal:  Circ Heart Fail       Date:  2016-07       Impact factor: 8.790

3.  Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.

Authors:  Franz Duca; Andreas A Kammerlander; Caroline Zotter-Tufaro; Stefan Aschauer; Marianne L Schwaiger; Beatrice A Marzluf; Diana Bonderman; Julia Mascherbauer
Journal:  Circ Cardiovasc Imaging       Date:  2016-12       Impact factor: 7.792

4.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Sherif F Nagueh; Otto A Smiseth; Christopher P Appleton; Benjamin F Byrd; Hisham Dokainish; Thor Edvardsen; Frank A Flachskampf; Thierry C Gillebert; Allan L Klein; Patrizio Lancellotti; Paolo Marino; Jae K Oh; Bogdan Alexandru Popescu; Alan D Waggoner
Journal:  J Am Soc Echocardiogr       Date:  2016-04       Impact factor: 5.251

5.  Comprehensive Echocardiographic and Cardiac Magnetic Resonance Evaluation Differentiates Among Heart Failure With Preserved Ejection Fraction Patients, Hypertensive Patients, and Healthy Control Subjects.

Authors:  Ify R Mordi; Satnam Singh; Amelia Rudd; Janaki Srinivasan; Michael Frenneaux; Nikolaos Tzemos; Dana K Dawson
Journal:  JACC Cardiovasc Imaging       Date:  2017-08-16

6.  Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.

Authors:  Viviany R Taqueti; Scott D Solomon; Amil M Shah; Akshay S Desai; John D Groarke; Michael T Osborne; Jon Hainer; Courtney F Bibbo; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Eur Heart J       Date:  2018-03-07       Impact factor: 29.983

Review 7.  Advances in parametric mapping with CMR imaging.

Authors:  Michael Salerno; Christopher M Kramer
Journal:  JACC Cardiovasc Imaging       Date:  2013-07

8.  Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography.

Authors:  Geraint Morton; Amedeo Chiribiri; Masaki Ishida; Shazia T Hussain; Andreas Schuster; Andreas Indermuehle; Divaka Perera; Juhani Knuuti; Stacey Baker; Erik Hedström; Paul Schleyer; Michael O'Doherty; Sally Barrington; Eike Nagel
Journal:  J Am Coll Cardiol       Date:  2012-09-19       Impact factor: 24.094

9.  Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome.

Authors:  Erik B Schelbert; Yaron Fridman; Timothy C Wong; Hussein Abu Daya; Kayla M Piehler; Ajay Kadakkal; Christopher A Miller; Martin Ugander; Maren Maanja; Peter Kellman; Dipan J Shah; Kaleab Z Abebe; Marc A Simon; Giovanni Quarta; Michele Senni; Javed Butler; Javier Diez; Margaret M Redfield; Mihai Gheorghiade
Journal:  JAMA Cardiol       Date:  2017-09-01       Impact factor: 14.676

10.  Diagnostic Performance of Fully Automated Pixel-Wise Quantitative Myocardial Perfusion Imaging by Cardiovascular Magnetic Resonance.

Authors:  Li-Yueh Hsu; Matthew Jacobs; Mitchel Benovoy; Allison D Ta; Hannah M Conn; Susanne Winkler; Anders M Greve; Marcus Y Chen; Sujata M Shanbhag; W Patricia Bandettini; Andrew E Arai
Journal:  JACC Cardiovasc Imaging       Date:  2018-02-14
View more
  9 in total

1.  The myocardial flow reserve in patients with heart failure with preserved ejection fraction.

Authors:  Andrew V Mochula; Kristina V Kopeva; Alina N Maltseva; Elena V Grakova; Marina Gulya; Andrey V Smorgon; Anna Gusakova; Konstantin V Zavadovsky
Journal:  Heart Vessels       Date:  2022-09-01       Impact factor: 1.814

Review 2.  Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis.

Authors:  Joanna M Bilak; Uazman Alam; Christopher A Miller; Gerry P McCann; Jayanth R Arnold; Prathap Kanagala
Journal:  Card Fail Rev       Date:  2022-07-01

Review 3.  Evaluating the adverse outcome of subtypes of heart failure with preserved ejection fraction defined by machine learning: A systematic review focused on defining high risk phenogroups.

Authors:  Simon W Rabkin
Journal:  EXCLI J       Date:  2022-02-22       Impact factor: 4.068

Review 4.  Non-invasive Imaging in Women With Heart Failure - Diagnosis and Insights Into Disease Mechanisms.

Authors:  Rebecca Kozor; Aderonke Abiodun; Katharine Kott; Charlotte Manisty
Journal:  Curr Heart Fail Rep       Date:  2022-05-04

Review 5.  Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs?

Authors:  Lauriane Cornuault; Paul Rouault; Cécile Duplàa; Thierry Couffinhal; Marie-Ange Renault
Journal:  Front Physiol       Date:  2022-07-08       Impact factor: 4.755

Review 6.  The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction.

Authors:  Clement Lau; Mohamed M M Elshibly; Prathap Kanagala; Jeffrey P Khoo; Jayanth Ranjit Arnold; Sandeep Singh Hothi
Journal:  Front Cardiovasc Med       Date:  2022-07-18

Review 7.  Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?

Authors:  Mark Sweeney; Ben Corden; Stuart A Cook
Journal:  EMBO Mol Med       Date:  2020-09-21       Impact factor: 12.137

Review 8.  Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets.

Authors:  Paolo Severino; Andrea D'Amato; Silvia Prosperi; Francesca Fanisio; Lucia Ilaria Birtolo; Bettina Costi; Lucrezia Netti; Cristina Chimenti; Carlo Lavalle; Viviana Maestrini; Massimo Mancone; Francesco Fedele
Journal:  Int J Mol Sci       Date:  2021-07-17       Impact factor: 6.208

Review 9.  Noninvasive Cardiac Imaging in Formerly Preeclamptic Women for Early Detection of Subclinical Myocardial Abnormalities: A 2022 Update.

Authors:  Yentl Brandt; Chahinda Ghossein-Doha; Suzanne C Gerretsen; Marc E A Spaanderman; M Eline Kooi
Journal:  Biomolecules       Date:  2022-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.